- Real-world data and real-world evidence in regulatory decision making
- MedDRA Labeling Groupings
- Good Governance Practice in Research Institutions
- Working Group XI – Patient Involvement
- Clinical research in resource-limited settings
- Drug-induced liver injury (DILI)
- Standardised MedDRA queries (SMQs)
- Vaccine safety
- Bioethics
- Working Group X – Meta-analysis
- Working Group IX – Risk minimisation
- Working Group VIII – Signal detection
- Vaccine pharmacovigilance